Pipelines for NewCo & Licensing
Welcome to Unibest's Pipeline Insights, your gateway to cutting-edge pharmaceutical innovation. In this blog collection, we unveil our open pipelines for NewCo development and licensing opportunities, offering valuable insights into promising molecular targets, innovative drug candidates, and the diseases we aim to conquer. Whether you're a potential partner, investor, or industry enthusiast, explore how Unibest is shaping the future of medicine through groundbreaking research and collaborative opportunities. Dive into our collection to discover how we're working to transform patient care and contribute to global health improvements, one pipeline at a time.

reteplase product.png
Reteplase: A Market-tested Thrombolytic Agent for Your Portfolio

Reteplase: A Market-tested Thrombolytic Agent for Your PortfolioIntroduction to Thrombolytic DrugsThrombolytic drugs play a crucial role in treating various venous and arterial thromboembolic conditions, particularly acute myocardial infarction.

READ MORE

CALL US

+86-574-27855666

QUICK LINKS

ABOUT UNIBEST

PRODUCTS

OUR SERVICE

RESPONSIBILITY

SEARCH PRODUCT :

Products are for R&D use only and are not intended for human use. We do not sell to patients.

Copyright© 2024 Unibest Industrial Co., Ltd. All Rights Reserved.